González R, Soza A, Hernández V, Pérez RM, Álvarez M, Morales A, Arellano M, Riquelme A, Viviani P, Covarrubias C, Arrese M, Miquel JF, Nervi F

Language: English
References: 26
Page: 127-130
PDF size: 72.69 Kb.

Text Extraction

Chronic hepatitis C is a major cause of liver-related morbidity and mortality. Epidemiological data regarding this infection in developing countries is scanty. Methods: Prevalence of hepatitis C (HCV) infection was investigated in a random sample of Chilean general adult population older than 20 years of age. Additionally, frequency of HCV infection was assessed in group of native Chilean Amerindians (Mapuche Indians) living in an isolated locality of the Southern Chile. Incidence of HCV infection was estimated using serum samples separated by 7 years (1993-2000). Results: Among 959 subjects, prevalence of anti-HCV antibodies was 1.15% (95% CI 0.48-1.82%) and 0.83% when only RIBA-confirmed cases were considered. Among these subjects, 62.5% had detectable HCV RNA in serum and 40% of them had a history of blood transfusion. Age distribution of cases showed a steadily increasing prevalence with age. Estimated incidence of new HCV infections was 15 per 100,000 subjects per year in the period 1993-2000. No cases were detected among the 145 Mapuche subjects studied. Conclusions: HCV infection is a prevalent disease in the Hispanic population of Chile with a low incidence in the last decade, whereas it was not detected in an isolated Mapuche Indian community. Age distribution of prevalence suggests that the peak of infection in Chile occurred 30 to 50 years ago.

REFERENCES

1. Brown RS Jr, Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transpl 2003; 9: S10-13.

2. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999; 6: 35-47.

3. Memon MI, Memon MA. Hepatitis C: an epidemiological review. J Viral Hepat 2002; 9: 84-100.

4. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-1466.

5. Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hurter D, Nawrocki M, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998; 28: 1687-1695.

6. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000; 132: 296-305.

7. Dienstag JL. The natural history of chronic hepatitis C and what we should do about it. Gastroenterology 1997; 112: 651-655.

8. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.

9. Rakela J, Vargas HE. Hepatitis C: magnitude of the problem. Liver Transpl 2002; 8: S3-6.

10. Buckel E, Uribe M, Brahm J, Silva G, Ferrario M, Godoy J, Segovia R, et al. Outcomes of orthotopic liver transplantation in Chile. Transplant Proc 2003; 35: 2509-2510.

11. Covarrubias C, Chianale J, Aldunce M. Detection of antibody to hepatitis C virus in Chilean blood donors, patient with chronic liver disease and high risk subjects. Gastroenterology 1998; 115: A577.

12. Wolff C, Jiron MI, Elgueta R, Vera M, Toriello L, Martinez L, Parraguez A. Prevalence of antibody to hepatitis C virus in blood donors. Analysis of confirmed results. Rev Med Chil 1996; 124: 615-616.

13. Munoz G, Velasco M, Thiers V, Hurtado C, Brahm J, Larrondo-Lillo M, Guglielmetti A, et al. Prevalence and genotypes of hepatitis C virus in blood donors and in patients with chronic liver disease and hepatocarcinoma in a Chilean population. Rev Med Chil 1998; 126: 1035-1042.

14. Gonzalez R, Vollrath V, Pereira J, Covarrubias C, Vacarezza A, Chianale J. Prevalence of hepatitis C virus RNA in hemodialysis patients: comparison of four antibody assays. Nephron 1995; 69: 181-182.

15. Quero MS, Suarez M, Munoz G, Torres M, Pena M. Prevalence of hepatitis C virus antibodies in pregnant women in Santiago. Rev Med Chil 1995; 123: 907-908.

16. Wolff C, Armas R, Puig A, Krause P, Parraguez A. Hepatitis C virus infection in patients with porphyria. Rev Med Chil 1994; 122: 294-298.

17. Miquel JF, Covarrubias C, Villaroel L, Mingrone G, Greco AV, Puglielli L, Carvallo P, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology 1998; 115: 937-946.

18. Matson GA, Sutton HE, Etcheverry RB, Swanson J, Robinson A. Distribution of hereditary blood groups among Indians in South America. 1970; 27: 157-194.

19. Chakaraborty R. Gene admixture in human populations, models and predictions. Yearbook Phys Anthropol 1986; 29: 1-43.

20. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.

21. Horai S, Kondo R, Nakagawa-Hattori Y, Hayashi S, Sonoda S, Tajima K. Peopling of the Americas, founded by four major lineages of mitochondrial DNA. Mol Biol Evol 1993; 10: 23-47.

22. Ginther C, Corach D, Penacino GA, Rey JA, Carnese FR, Hutz MH, Anderson A, et al. Genetic variation among the Mapuche Indians from the Patagonian region of Argentina: mitochondrial DNA sequence variation and allele frequencies of several nuclear genes. In: Pena SDJ, Chakraborty R, Epplen JT, Jeffreys AJ, eds. DNA fingerprinting: state of the science. Basel: Birkhauser Verlag, 1993: 214-219.

23. Hepatitis C - Global prevalence (update). Wkly Epidemiol Rec 1999; 74: 425-427.

24. Murphy EL, Bryzman S, Williams AE, Co-Chien H, Schreiber GB, Ownby HE, Gilcher RO, et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. Jama 1996; 275: 995-1000.

25. Soza A, Arrese M, Gonzalez R, Alvarez M, Perez RM, Cortes P, Patillo A, et al. Clinical and epidemiological features of 147 Chilean patients with chronic hepatitis C. Ann Hepatol 2004; 3: 146-151.

26. Centers for Disease Control and Prevention. Estimated Incidence of Acute HCV Infection United States, 1960-2001. http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_c/hcv_epi_for_distrib_000925.ppt 2003.